Advanced Oncotherapy PLC Holding(s) in Company (2377A)
December 22 2017 - 5:24AM
UK Regulatory
TIDMAVO
RNS Number : 2377A
Advanced Oncotherapy PLC
22 December 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
------------------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying Advanced Oncotherapy Plc
issuer
of existing shares to which voting rights
are
attached: (ii)
----------------------------------------------------------------------- -----------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
--------------------------------------------------------------------------- -------------------------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
--------------------------------------------------------------------------- -------------------------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
--------------------------------------------------------------------------- -------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------- -------------------------
Other (please
specify):
------------------------------------------------------------------- ------ -------------------------
3. Full name of person(s) subject Mr Alberto Colussi
to the
notification obligation: (iii)
--------------------------------------------------------------------- -------------------------------
4. Full name of shareholder(s) Mr Alberto Colussi
(if different from 3.):(iv) Brahma AG
--------------------------------------------------------------------- -------------------------------
5. Date of the transaction and date 19 December 2017
on
which the threshold is crossed
or
reached: (v)
--------------------------------------------------------------------- -------------------------------
6. Date on which issuer notified: 21 December 2017
--------------------------------------------------------------------- -------------------------------
7. Threshold(s) that is/are crossed Below 12%
or
reached: (vi, vii)
--------------------------------------------------------------------- -------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ---------------------------------- -------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
------------- ---------------- ---------------- -------------- ---------------------- ---------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ -------------- --------- ----------- ------------ -------------
Ordinary
shares
(GBP 0.25)
GB00BD6SX109 9,837,306 9,837,306 0 0 9,657,306 0% 11.93%
---------------- ---------------- -------------- --------- ----------- ------------ -------------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date (xiii) Conversion Period rights that may rights
instrument (xiv) be
acquired if the
instrument is
exercised/ converted.
----------------- -------------- -------------------------------- ------------------------ -----------------------
N/A
----------------- -------------- -------------------------------- ------------------------ -----------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
--------------- -------------- -------------- ---------------- ------------------------ -------------------------
N/A Nominal Delta
--------------- -------------- -------------- ---------------- ------------------------ ------------ -----------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------- -----------------------------------------------------------------
9,657,306 11.93%
--------------------------------------------------- -----------------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
-----------------------------------------------------------------------------------------------
Mr Alberto Colussi's direct holding in Brahma AG is 100%
Proxy Voting:
-----------------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
----------------------------------------------------------------------- ----------------------
11. Number of voting rights proxy holder will N/A
cease
to hold:
----------------------------------------------------------------------- ----------------------
12. Date on which proxy holder will cease to N/A
hold
voting rights:
----------------------------------------------------------------------- ----------------------
N/A
13. Additional information:
---------------------------------------------------------------------- -----------------------
14. Contact name: Graham Pughe, AVO Plc
---------------------------------------------------------------------- -----------------------
15. Contact telephone number: 0203 761 4995
----------------------------------------------------------------------- ----------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUUARBSAUUAA
(END) Dow Jones Newswires
December 22, 2017 06:24 ET (11:24 GMT)
Advanced Oncotherapy (LSE:AVO)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Oncotherapy (LSE:AVO)
Historical Stock Chart
From May 2023 to May 2024